London-based INDIVA (TSXV:NDVA) was recently featured in an article on CBC touching upon the company’s expansion plans of adding “30,000 square feet of space and dozens of jobs to its current 10,000 square foot (cannabis) growing and production facility.”
Notable among the products the company is working on are cannabidiol salt and sugar, which could give “seasonings the same analgesic, anti-inflammatory and anti-anxiety properties that medical grade cannabis provides.”
INDIVA Co-founder, President and CEO Neil Marrotta also said that the company is working on a new line of recreational cannabis products that will be launched once legalization takes effect. Naturally, there’s still a lot of back and forth that remains between the upper chamber and the House of Commons. For instance, the Senate recently proposed 46 amendments to The Cannabis Act and while some have been accepted, several major ones have been passed over.
To read the full interview, click here.